Tokushima, Japan

Akihito Watanabe



 

Average Co-Inventor Count = 22.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Akihito Watanabe: Innovator in Pharmaceutical Compounds

Introduction

Akihito Watanabe is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as monoamines reuptake inhibitors. With a total of 5 patents to his name, Watanabe's work is recognized for its potential therapeutic applications.

Latest Patents

Watanabe's latest patents include innovative N,N-substituted 3-aminopyrrolidine compounds. These compounds are described as useful for their ability to act as monoamines reuptake inhibitors. The invention provides a pyrrolidine compound of General Formula (1) or a salt thereof, where R and R' are each independently a phenyl group or a pyridyl group. The phenyl or pyridyl groups may have one or more substituents selected from halogen atoms and lower alkyl groups, which can also be optionally substituted with halogen atoms. This compound is designed to produce a pharmaceutical preparation that has a wider therapeutic spectrum and can exhibit sufficient therapeutic effects after short-term administration.

Career Highlights

Watanabe is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of pyrrolidine compounds in medicine.

Collaborations

Watanabe has collaborated with notable coworkers such as Muneaki Kurimura and Shinichi Taira. Their combined expertise has contributed to the successful development of various pharmaceutical innovations.

Conclusion

Akihito Watanabe's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor. His work continues to pave the way for advancements in therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…